• 3 minutes e-car sales collapse
  • 6 minutes America Is Exceptional in Its Political Divide
  • 11 minutes Perovskites, a ‘dirt cheap’ alternative to silicon, just got a lot more efficient
  • 42 mins GREEN NEW DEAL = BLIZZARD OF LIES
  • 7 days Solving The Space Problem For America’s Solar Industry
  • 29 mins Russian Officials Voice Concerns About Chinese-Funded Rail Line
  • 6 hours Investment in renewables tanking
  • 20 hours If hydrogen is the answer, you're asking the wrong question
  • 1 day "Mexico Plans to Become an Export Hub With US-Drilled Natural Gas" - Bloomberg - (See image)
  • 2 days How Far Have We Really Gotten With Alternative Energy
Russia’s Seaborne Oil Exports Dip But Remain High

Russia’s Seaborne Oil Exports Dip But Remain High

Russia’s crude oil exports dip…

Companies Lash Out At SEC’s Proposed Scope 3 Rules

Companies Lash Out At SEC’s Proposed Scope 3 Rules

A new climate-risk disclosure rule…

Editorial Dept

Editorial Dept

More Info

Premium Content

Oil Prices Are On Course For Another Weekly Gain

U.S. West Texas Intermediate crude oil futures are putting in a mixed performance on Friday on low post-holiday volume. Earlier in the session, the U.S. futures contract fell more than 1% amid concerns about oversupply and doubts about a vaccine to end the coronavirus pandemic, but at the mid-session, the market is trading higher, putting it on course for a fourth straight week of gains ahead of an OPEC+ meeting early next week.

Vaccine Issues Encouraging Profit-Taking

In a slow news week, traders were once again focusing on a coronavirus vaccine, but this time, they appear to be booking profits after a big price jump as several scientists have sounded doubts over how robust the results of trials from AstraZeneca were.

Earlier in the week, both oil benchmarks jumped about 6% after AstraZeneca announced that its COVID-19 vaccine could be up to 90% effective, adding to successful trial results of Pfizer and Moderna Inc under development in the fight to end the worst pandemic in a century.

However, former pharmaceutical executives in the U.S. raised questions this week over the Oxford-AstraZeneca vaccine candidate. “We believe that this product will never be licensed in the U.S.,” one group of critical U.S.-based analysts wrote this week.

US Crude Stockpiles Fall Unexpectedly, Gasoline Builds:  EIA

U.S. crude oil inventories fell last week, as well as distillate stocks, while gasoline stockpiles rose sharply, the U.S. Energy…





Leave a comment

Leave a comment




EXXON Mobil -0.35
Open57.81 Trading Vol.6.96M Previous Vol.241.7B
BUY 57.15
Sell 57.00
Oilprice - The No. 1 Source for Oil & Energy News